Target intelligence / Profile preview

Paracrine ligand–receptor network

Molecular classification
Other
01

Overview

A paracrine ligand–receptor network refers to a fundamental mode of cell-to-cell communication where a cell produces a signal (ligand) to induce changes in nearby cells, altering the behavior or differentiation of those cells (Nature, 2023). Unlike endocrine signaling, which uses the circulatory system to transport ligands over long distances, paracrine signals diffuse through the extracellular matrix to act locally (NIH, 2022). This network is composed of diverse molecular families, including growth factors, cytokines, and neurotransmitters, along with their cognate receptors such as receptor tyrosine kinases and G protein-coupled receptors. These interactions are critical for maintaining tissue homeostasis, coordinating immune responses, and guiding embryonic development. In many diseases, particularly cancer, these networks are dysregulated; for instance, tumor cells may hijack paracrine signaling to recruit stromal cells or promote angiogenesis (PubMed, 2021). While the network itself is not a single therapeutic target, its individual components are frequently targeted by monoclonal antibodies and small molecule inhibitors to disrupt pathological signaling loops. Therapeutic strategies often focus on blocking the ligand-receptor interface or inhibiting the downstream intracellular signaling cascades initiated by these local interactions. Understanding the spatial and temporal dynamics of these networks is essential for developing precision medicines that can selectively modulate local environments without systemic toxicity.

Other names
Paracrine signalingLocal cell-cell communicationParacrine loopLocal signaling network
02

Mechanism of action

Antagonism of specific ligands or receptors to disrupt local signaling loops within the tissue microenvironment.

03

Biological functions

Signal transductionCell-cell communicationTissue homeostasisInflammationDevelopment
04

Disease associations

CancerInflammationFibrosisAutoimmune disease
05

Safety considerations

Impaired wound healingImmunosuppressionOff-target systemic effects from disrupting homeostatic local signalingCompensatory upregulation of alternative pathways
06

Interacting drugs

Bevacizumab

4 more in the full profile.

07

Biomarkers

Cytokine expression profilesReceptor occupancyPhospho-protein levelsLigand concentration in interstitial fluid

Beyond the preview

Go deeper on Paracrine ligand–receptor network.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paracrine ligand–receptor network.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call